000			02196nam a2200445 i 4500
001			on1048596841
003			OCoLC
005			20190208144232.0
006			m o d f
007			cr bn||||a||||
008			180815s2018 dcu o f000 0 eng c
040			_aGPO _beng _erda _epn _cGPO _dGPO _dMvI
042			_apcc
043			_an-us---
050		4	_aKF27 _b.J874 2018
074			_a1020-C (online)
088			_aSerial no. 115-28 (United States. Congress. House. Committee on the Judiciary)
086	0		_aY 4.J 89/1:115-28
099			_aY 4.J 89/1:115-28
110	1		_aUnited States. _bCongress. _bHouse. _bCommittee on the Judiciary. _bSubcommittee on Regulatory Reform, Commercial and Antitrust Law, _eauthor.
245	1	0	_aCompetition in the pharmaceutical supply chain : _bthe proposed merger of CVS Health and Aetna : hearing before the Subcommittee on Regulatory Reform, Commercial and Antitrust Law of the Committee on the Judiciary, House of Representatives, One Hundred Fifteenth Congress, second session, February 27, 2018.
246	3	0	_aProposed merger of CVS Health and Aetna
264		1	_aWashington : _bU.S. Government Publishing Office, _c2018.
300			_a1 online resource (iii, 39 pages)
336			_btxt
337			_bc _2rdamedia
338			_bcr _2rdacarrier
588			_aDescription based on online resource; title from PDF title screens (govinfo web site, viewed on Aug. 15, 2018).
500			_a"Serial no. 115-28."
500			_aCRDP Program record.
650		0	_aConsolidation and merger of corporations _zUnited States.
610	2	0	_aCVS/pharmacy (Firm)
610	2	0	_aAetna Health Plans.
650		0	_aPharmaceutical industry _xMergers _zUnited States.
650		0	_aCompetition _zUnited States.
655		7	_aLegislative hearings. _2lcgft
776	0	8	_iPrint version: _aUnited States. Congress. House. Committee on the Judiciary. Subcommittee on Regulatory Reform, Commercial and Antitrust Law. _tCompetition in the pharmaceutical supply chain _w(OCoLC)1048598806
856	4	0	_3PDF version _uhttps://purl.fdlp.gov/GPO/gpo107436
856	4	0	_3Text version _uhttps://purl.fdlp.gov/GPO/gpo107437
999			_c278674 _d278674